Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report
- DOI
- 10.32604/or.2026.083193
- Published
- 2026
- Container
- Oncology Research
- Publisher
- Tech Science Press
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.32604/or.2026.083193,
title = {Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report},
author = {Waseem Abdelrahim and Ebtesam Al-Najjar and Seif El Beheary and Abdullah Esmail},
year = {2026},
journal = {Oncology Research},
doi = {10.32604/or.2026.083193},
url = {https://doi.org/10.32604/or.2026.083193}
}RIS
TY - JOUR TI - Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report AU - Waseem Abdelrahim AU - Ebtesam Al-Najjar AU - Seif El Beheary AU - Abdullah Esmail PY - 2026 JO - Oncology Research DO - 10.32604/or.2026.083193 UR - https://doi.org/10.32604/or.2026.083193 ER -
APA
Abdelrahim, W., Al-Najjar, E., Beheary, S. E., & Esmail, A. (2026). Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report. Oncology Research. https://doi.org/10.32604/or.2026.083193
Source records
- crossref · retrieved 2026-09-25T04:05:33.290Z